Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid Leukemia

Published:2023-09 Issue:9 Volume:29 Page:578.e1-578.e9
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Abid Muhammad Bilal^ORCID,Estrada-Merly Noel,Zhang Mei-Jie,Chen Karen,Allan David^ORCID,Bredeson Christopher,Sabloff Mitchell^ORCID,Guru Murthy Guru Subramanian,Badar Talha^ORCID,Hashmi Shahrukh,Aljurf Mahmoud^ORCID,Litzow Mark R.,Kebriaei Partow,Hourigan Christopher S.,Saber Wael

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference37 articles.

1. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program database. Available at: https://seer.cancer.gov. Accessed March 17, 2023.

2. Allogeneic hematopoietic cell transplantation for older patients;Lin;Hematology Am Soc Hematol Educ Program,2021

3. Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome;Myllymäki;Blood,2020

4. Age-related clonal hematopoiesis associated with adverse outcomes;Jaiswal;N Engl J Med,2014

5. Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation;Chambers;PLoS Biol,2007

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic hematopoietic cell transplantation from alternative donors in acute myeloid leukemia;Annals of Hematology;2024-08-17

2. Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamide;Leukemia;2024-07-24

3. Unrelated hematopoietic stem cell donor registries: present reality and future prospects;Current Opinion in Hematology;2024-07-22

4. Comparison of Older Related versus Younger Unrelated Donors for Older Recipients of Allogeneic Hematopoietic Cell Transplantation with Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Large Single-Center Analysis;Transplantation and Cellular Therapy;2024-07

5. Optimizing Outcomes in Mismatched Unrelated Donor Allogeneic Transplantation: Post-Transplant Cyclophosphamide’s Dual Impact on Graft versus Host Disease Incidence and Overall Survival: Retrospective Analysis on Behalf of Polish Adult Leukemia Group;Journal of Clinical Medicine;2024-06-18